Linked e-resources
Details
Table of Contents
Intro
Preface
Contents
Contributors
Chapter 1: Current Patterns of Tobacco Use and Health Disparities
Introduction
Health Equity in the Context of Tobacco and Understanding Tobacco-Related Disparities
Why Should We Recognize Tobacco-Related Disparities?
Poorer Outcomes for Those Who Face Disparities
Higher Cost for Those Who Face Disparities
Higher Tobacco Use and Secondhand Smoke Exposure Among Those Impacted by Tobacco-Related Disparities
Patterns of Tobacco Use in Various Populations
Age
Education
Gender
Race/Ethnicity
Income/Poverty
Other Tobacco Products (OTP)
Secondhand Smoke Exposure
Sexual Orientation and Gender Identity
Substance Use and Mental Health Disorders
Occupation and Veteran Status
Disability
Geography
Incarcerated People
Why Do Tobacco-Related Disparities Exist?
Social Determinants of Health
Targeted Marketing by the Tobacco Industry
Lack of Comprehensive Policies
Changing US Population
What Can We Do to Eliminate Disparities and Achieve Health Equity?
Increasing Diversity of the Healthcare Team
Address Inequities in Research
Solving Inequalities in Access, Quality of Care, and Socioeconomic Status
Implementing Appropriate Tobacco Control Policies
References
Chapter 2: Adverse Effects of Tobacco Products (Cigarettes, E-Cigarettes, Hookah, Smokeless Tobacco) Use on Health
Introduction: Impact on Health of All Tobacco Products
Mechanism of Injury of Tobacco Products
Pathophysiology
Oxidative Stress
Genetics and Epigenetics
Endothelial Dysfunction
Inflammation and Infection
Hemodynamic Effects
Thrombogenic Effects
Hormonal Alterations
Lipid Abnormalities
Specific Pathophysiology Related to Modes of Delivery and Additive Toxins
Cigarettes
Hookah
Vaping and Electronic Nicotine Delivery Systems (ENDS)
Smokeless Tobacco
Organ-Specific Morbidity and Mortality Attributed to Tobacco Product Use
Pulmonary Manifestations
Acute Respiratory Infection
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Respiratory Bronchiolitis Associated Interstitial Lung Disease (RB-ILD)
Desquamative Interstitial Pneumonia (DIP)
Pulmonary Langerhans Cell Histiocytosis (PLCH)
Cardiovascular Manifestations
Subclinical Atherosclerosis
Peripheral Arterial Disease
Coronary Heart Disease
Cerebrovascular Disease
Aortic Aneurysm
Atrial Fibrillation
Oncological Manifestations
Lung
Head and Neck
Gastrointestinal (Esophageal, Gastric, Colorectal, Hepatobiliary, Pancreas)
Genitourinary
Blood
Reproductive Manifestations
Female Reproductive Health
Male Reproductive Health
Pregnancy Complications
Perinatal and Infant Morbidity and Mortality
Endocrine Manifestations
Neuropsychiatric Manifestations
Miscellaneous Manifestations
Health Benefits of Cessation
Summary
References
Preface
Contents
Contributors
Chapter 1: Current Patterns of Tobacco Use and Health Disparities
Introduction
Health Equity in the Context of Tobacco and Understanding Tobacco-Related Disparities
Why Should We Recognize Tobacco-Related Disparities?
Poorer Outcomes for Those Who Face Disparities
Higher Cost for Those Who Face Disparities
Higher Tobacco Use and Secondhand Smoke Exposure Among Those Impacted by Tobacco-Related Disparities
Patterns of Tobacco Use in Various Populations
Age
Education
Gender
Race/Ethnicity
Income/Poverty
Other Tobacco Products (OTP)
Secondhand Smoke Exposure
Sexual Orientation and Gender Identity
Substance Use and Mental Health Disorders
Occupation and Veteran Status
Disability
Geography
Incarcerated People
Why Do Tobacco-Related Disparities Exist?
Social Determinants of Health
Targeted Marketing by the Tobacco Industry
Lack of Comprehensive Policies
Changing US Population
What Can We Do to Eliminate Disparities and Achieve Health Equity?
Increasing Diversity of the Healthcare Team
Address Inequities in Research
Solving Inequalities in Access, Quality of Care, and Socioeconomic Status
Implementing Appropriate Tobacco Control Policies
References
Chapter 2: Adverse Effects of Tobacco Products (Cigarettes, E-Cigarettes, Hookah, Smokeless Tobacco) Use on Health
Introduction: Impact on Health of All Tobacco Products
Mechanism of Injury of Tobacco Products
Pathophysiology
Oxidative Stress
Genetics and Epigenetics
Endothelial Dysfunction
Inflammation and Infection
Hemodynamic Effects
Thrombogenic Effects
Hormonal Alterations
Lipid Abnormalities
Specific Pathophysiology Related to Modes of Delivery and Additive Toxins
Cigarettes
Hookah
Vaping and Electronic Nicotine Delivery Systems (ENDS)
Smokeless Tobacco
Organ-Specific Morbidity and Mortality Attributed to Tobacco Product Use
Pulmonary Manifestations
Acute Respiratory Infection
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Respiratory Bronchiolitis Associated Interstitial Lung Disease (RB-ILD)
Desquamative Interstitial Pneumonia (DIP)
Pulmonary Langerhans Cell Histiocytosis (PLCH)
Cardiovascular Manifestations
Subclinical Atherosclerosis
Peripheral Arterial Disease
Coronary Heart Disease
Cerebrovascular Disease
Aortic Aneurysm
Atrial Fibrillation
Oncological Manifestations
Lung
Head and Neck
Gastrointestinal (Esophageal, Gastric, Colorectal, Hepatobiliary, Pancreas)
Genitourinary
Blood
Reproductive Manifestations
Female Reproductive Health
Male Reproductive Health
Pregnancy Complications
Perinatal and Infant Morbidity and Mortality
Endocrine Manifestations
Neuropsychiatric Manifestations
Miscellaneous Manifestations
Health Benefits of Cessation
Summary
References